vs
Reynolds Consumer Products Inc.（REYN）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Reynolds Consumer Products Inc.的季度营收约是Revvity的1.3倍（$1.0B vs $772.1M），Revvity净利率更高（12.7% vs 11.4%，领先1.3%），Revvity同比增速更快（5.9% vs 1.2%），Reynolds Consumer Products Inc.自由现金流更多（$200.0M vs $161.8M），过去两年Reynolds Consumer Products Inc.的营收复合增速更高（11.4% vs 9.0%）
雷诺消费品公司旗下的Rival是美国小家电制造商，拥有Bionaire、Crock-Pot、Rival等多个知名品牌。1999年成为Holmes产品集团全资子公司，2005年随Holmes被Jarden收购，后Jarden与纽威尔橡胶美合并，现隶属于纽威尔集团。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
REYN vs RVTY — 直观对比
营收规模更大
REYN
是对方的1.3倍
$772.1M
营收增速更快
RVTY
高出4.7%
1.2%
净利率更高
RVTY
高出1.3%
11.4%
自由现金流更多
REYN
多$38.2M
$161.8M
两年增速更快
REYN
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $772.1M |
| 净利润 | $118.0M | $98.4M |
| 毛利率 | 25.7% | — |
| 营业利润率 | 14.8% | 14.5% |
| 净利率 | 11.4% | 12.7% |
| 营收同比 | 1.2% | 5.9% |
| 净利润同比 | -1.7% | 3.9% |
| 每股收益（稀释后） | $0.55 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收REYNRVTY
| Q4 25 | $1.0B | $772.1M | ||
| Q3 25 | $931.0M | $698.9M | ||
| Q2 25 | $938.0M | $720.3M | ||
| Q1 25 | $818.0M | $664.8M | ||
| Q4 24 | $1.0B | $729.4M | ||
| Q3 24 | $910.0M | $684.0M | ||
| Q2 24 | $930.0M | $691.7M | ||
| Q1 24 | $833.0M | $649.9M |
净利润REYNRVTY
| Q4 25 | $118.0M | $98.4M | ||
| Q3 25 | $79.0M | $46.7M | ||
| Q2 25 | $73.0M | $53.9M | ||
| Q1 25 | $31.0M | $42.2M | ||
| Q4 24 | $120.0M | $94.6M | ||
| Q3 24 | $86.0M | $94.4M | ||
| Q2 24 | $97.0M | $55.4M | ||
| Q1 24 | $49.0M | $26.0M |
毛利率REYNRVTY
| Q4 25 | 25.7% | — | ||
| Q3 25 | 25.0% | 53.6% | ||
| Q2 25 | 24.1% | 54.5% | ||
| Q1 25 | 23.1% | 56.5% | ||
| Q4 24 | 27.6% | — | ||
| Q3 24 | 26.3% | 56.3% | ||
| Q2 24 | 27.5% | 55.7% | ||
| Q1 24 | 24.1% | 54.6% |
营业利润率REYNRVTY
| Q4 25 | 14.8% | 14.5% | ||
| Q3 25 | 11.0% | 11.7% | ||
| Q2 25 | 10.2% | 12.6% | ||
| Q1 25 | 5.1% | 10.9% | ||
| Q4 24 | 15.5% | 16.3% | ||
| Q3 24 | 12.4% | 14.3% | ||
| Q2 24 | 12.4% | 12.4% | ||
| Q1 24 | 7.8% | 6.8% |
净利率REYNRVTY
| Q4 25 | 11.4% | 12.7% | ||
| Q3 25 | 8.5% | 6.7% | ||
| Q2 25 | 7.8% | 7.5% | ||
| Q1 25 | 3.8% | 6.4% | ||
| Q4 24 | 11.7% | 13.0% | ||
| Q3 24 | 9.5% | 13.8% | ||
| Q2 24 | 10.4% | 8.0% | ||
| Q1 24 | 5.9% | 4.0% |
每股收益（稀释后）REYNRVTY
| Q4 25 | $0.55 | $0.86 | ||
| Q3 25 | $0.38 | $0.40 | ||
| Q2 25 | $0.35 | $0.46 | ||
| Q1 25 | $0.15 | $0.35 | ||
| Q4 24 | $0.57 | $0.77 | ||
| Q3 24 | $0.41 | $0.77 | ||
| Q2 24 | $0.46 | $0.45 | ||
| Q1 24 | $0.23 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $147.0M | $919.9M |
| 总债务越低越好 | $1.6B | — |
| 股东权益账面价值 | $2.3B | $7.3B |
| 总资产 | $4.9B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.70× | — |
8季度趋势，按日历期对齐
现金及短期投资REYNRVTY
| Q4 25 | $147.0M | $919.9M | ||
| Q3 25 | $53.0M | $931.4M | ||
| Q2 25 | $57.0M | $991.8M | ||
| Q1 25 | $58.0M | $1.1B | ||
| Q4 24 | $137.0M | $1.2B | ||
| Q3 24 | $96.0M | $1.2B | ||
| Q2 24 | $101.0M | $2.0B | ||
| Q1 24 | $135.0M | $1.7B |
总债务REYNRVTY
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $1.8B | — | ||
| Q1 24 | $1.8B | — |
股东权益REYNRVTY
| Q4 25 | $2.3B | $7.3B | ||
| Q3 25 | $2.2B | $7.4B | ||
| Q2 25 | $2.1B | $7.6B | ||
| Q1 25 | $2.1B | $7.6B | ||
| Q4 24 | $2.1B | $7.7B | ||
| Q3 24 | $2.1B | $7.9B | ||
| Q2 24 | $2.0B | $7.9B | ||
| Q1 24 | $2.0B | $7.8B |
总资产REYNRVTY
| Q4 25 | $4.9B | $12.2B | ||
| Q3 25 | $4.9B | $12.1B | ||
| Q2 25 | $4.9B | $12.4B | ||
| Q1 25 | $4.8B | $12.4B | ||
| Q4 24 | $4.9B | $12.4B | ||
| Q3 24 | $4.8B | $12.8B | ||
| Q2 24 | $4.9B | $13.4B | ||
| Q1 24 | $4.9B | $13.4B |
负债/权益比REYNRVTY
| Q4 25 | 0.70× | — | ||
| Q3 25 | 0.75× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.77× | — | ||
| Q4 24 | 0.79× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 0.92× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $237.0M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $200.0M | $161.8M |
| 自由现金流率自由现金流/营收 | 19.3% | 21.0% |
| 资本支出强度资本支出/营收 | 3.6% | 2.6% |
| 现金转化率经营现金流/净利润 | 2.01× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $316.0M | $509.4M |
8季度趋势，按日历期对齐
经营现金流REYNRVTY
| Q4 25 | $237.0M | $182.0M | ||
| Q3 25 | $93.0M | $138.5M | ||
| Q2 25 | $91.0M | $134.3M | ||
| Q1 25 | $56.0M | $128.2M | ||
| Q4 24 | $182.0M | $174.2M | ||
| Q3 24 | $124.0M | $147.9M | ||
| Q2 24 | $84.0M | $158.6M | ||
| Q1 24 | $99.0M | $147.6M |
自由现金流REYNRVTY
| Q4 25 | $200.0M | $161.8M | ||
| Q3 25 | $48.0M | $120.0M | ||
| Q2 25 | $51.0M | $115.5M | ||
| Q1 25 | $17.0M | $112.2M | ||
| Q4 24 | $141.0M | $149.8M | ||
| Q3 24 | $93.0M | $125.6M | ||
| Q2 24 | $65.0M | $136.6M | ||
| Q1 24 | $70.0M | $129.7M |
自由现金流率REYNRVTY
| Q4 25 | 19.3% | 21.0% | ||
| Q3 25 | 5.2% | 17.2% | ||
| Q2 25 | 5.4% | 16.0% | ||
| Q1 25 | 2.1% | 16.9% | ||
| Q4 24 | 13.8% | 20.5% | ||
| Q3 24 | 10.2% | 18.4% | ||
| Q2 24 | 7.0% | 19.7% | ||
| Q1 24 | 8.4% | 20.0% |
资本支出强度REYNRVTY
| Q4 25 | 3.6% | 2.6% | ||
| Q3 25 | 4.8% | 2.6% | ||
| Q2 25 | 4.3% | 2.6% | ||
| Q1 25 | 4.8% | 2.4% | ||
| Q4 24 | 4.0% | 3.4% | ||
| Q3 24 | 3.4% | 3.3% | ||
| Q2 24 | 2.0% | 3.2% | ||
| Q1 24 | 3.5% | 2.7% |
现金转化率REYNRVTY
| Q4 25 | 2.01× | 1.85× | ||
| Q3 25 | 1.18× | 2.97× | ||
| Q2 25 | 1.25× | 2.49× | ||
| Q1 25 | 1.81× | 3.03× | ||
| Q4 24 | 1.52× | 1.84× | ||
| Q3 24 | 1.44× | 1.57× | ||
| Q2 24 | 0.87× | 2.87× | ||
| Q1 24 | 2.02× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
REYN
| Reynolds Cooking And Baking | $397.0M | 38% |
| Hefty Waste And Storage | $247.0M | 24% |
| Tableware Products | $229.0M | 22% |
| Presto Products | $164.0M | 16% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
